Announcements Trials
Browse Landscape

Phase

Phase NA 29Phase 4 15Phase 3 4Phase 2 3Phase 1 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1Breast 1

Conditions

Neoplastic Cells, Circulating 1Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Cyclophosphamide 739Cisplatin 687Gemcitabine 641Bevacizumab 615Carboplatin 604Paclitaxel 600Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 360Capecitabine 342Filgrastim 333Etoposide 328Dexamethasone 312Irinotecan 309pembrolizumab 279Leucovorin 274Cetuximab 267Cytarabine 242Erlotinib Hydrochloride 231Prednisone 227Nivolumab 227Trastuzumab 225Bortezomib 221Vincristine 220Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Completed × Propofol × Clear all
NCT05502458 2022-08-16

Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor

Zhejiang Cancer Hospital

Phase 2 Completed
60 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Neoplastic Cells, Circulating

NCT02839668 2019-10-29

TIVA/TCI-BC

Iuliu Hatieganu University of Medicine and Pharmacy

Phase 2 Completed
120 enrolled
Breast

Breast Neoplasms

NCT01516684 2019-09-06

Local Anesthetic Cream in Younger Patients Undergoing Lumbar Punctures

Wake Forest University Health Sciences

Phase 2 Completed
33 enrolled 6 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡